Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy

Background The National Comprehensive Cancer Network (NCCN) guidelines for colon cancer recently added the following footnote regarding the therapeutic strategy for peritoneal metastases: “If R0 resection can be achieved, surgical resection of isolated peritoneal disease may be considered at experie...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Annals of surgical oncology Ročník 25; číslo 1; s. 173 - 178
Hlavní autoři:	Shida, Dai, Tsukamoto, Shunsuke, Ochiai, Hiroki, Kanemitsu, Yukihide
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Cham Springer International Publishing 01.01.2018
Témata:	Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Chemotherapy, Adjuvant Colorectal Cancer Colorectal Neoplasms - drug therapy Colorectal Neoplasms - pathology Colorectal Neoplasms - surgery Cytoreduction Surgical Procedures Female Fluorouracil - administration & dosage Humans Hyperthermia, Induced Lymph Node Excision Male Medicine Medicine & Public Health Metastasectomy Middle Aged Neoplasm, Residual Oncology Oxaliplatin - administration & dosage Peritoneal Neoplasms - drug therapy Peritoneal Neoplasms - pathology Peritoneal Neoplasms - secondary Peritoneal Neoplasms - surgery Prognosis Retrospective Studies Surgery Surgical Oncology Survival Rate Time Factors Tumor Burden NCCN guidelines Peritoneal metastasis R0 resection Colorectal cancer
ISSN:	1068-9265, 1534-4681, 1534-4681
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Background The National Comprehensive Cancer Network (NCCN) guidelines for colon cancer recently added the following footnote regarding the therapeutic strategy for peritoneal metastases: “If R0 resection can be achieved, surgical resection of isolated peritoneal disease may be considered at experienced centers.” This study investigated the efficacy of R0 resection of peritoneal metastasis from colorectal cancer without cytoreductive surgery or hyperthermic intraperitoneal chemotherapy (HIPEC). Methods This retrospective cohort study was conducted at a single-institution tertiary care cancer center. Among 496 consecutive M1c colorectal cancer patients, R0 resection was achieved for 94 patients (19%). The subjects were 78 consecutive patients with colorectal cancer and simultaneous peritoneal metastasis but no other distant metastases who underwent R0 resection at the National Cancer Center Hospital from 1971 to 2016 (16% of all M1c patients). Overall survival (OS) was investigated, and clinicopathologic variables were analyzed for prognostic significance. Results No perioperative mortality was noted. The 3-year OS rate was 45%, and the 5-year OS rate was 28.7%. The median survival time was 33.4 months. Notably, 17 patients survived for more than 5 years, and 9 of these patients did not receive any chemotherapy. Multivariate analysis showed cancer location in the colon and harvesting of 12 or more lymph nodes to be independent factors associated with a better prognosis. Conclusions From the perspective of long-term outcomes and no perioperative mortality, R0 resection of peritoneal metastasis from colorectal cancer, without complete peritonectomy or HIPEC, appeared to be an acceptable therapeutic option for some patients with peritoneal metastasis.
AbstractList	Background The National Comprehensive Cancer Network (NCCN) guidelines for colon cancer recently added the following footnote regarding the therapeutic strategy for peritoneal metastases: “If R0 resection can be achieved, surgical resection of isolated peritoneal disease may be considered at experienced centers.” This study investigated the efficacy of R0 resection of peritoneal metastasis from colorectal cancer without cytoreductive surgery or hyperthermic intraperitoneal chemotherapy (HIPEC). Methods This retrospective cohort study was conducted at a single-institution tertiary care cancer center. Among 496 consecutive M1c colorectal cancer patients, R0 resection was achieved for 94 patients (19%). The subjects were 78 consecutive patients with colorectal cancer and simultaneous peritoneal metastasis but no other distant metastases who underwent R0 resection at the National Cancer Center Hospital from 1971 to 2016 (16% of all M1c patients). Overall survival (OS) was investigated, and clinicopathologic variables were analyzed for prognostic significance. Results No perioperative mortality was noted. The 3-year OS rate was 45%, and the 5-year OS rate was 28.7%. The median survival time was 33.4 months. Notably, 17 patients survived for more than 5 years, and 9 of these patients did not receive any chemotherapy. Multivariate analysis showed cancer location in the colon and harvesting of 12 or more lymph nodes to be independent factors associated with a better prognosis. Conclusions From the perspective of long-term outcomes and no perioperative mortality, R0 resection of peritoneal metastasis from colorectal cancer, without complete peritonectomy or HIPEC, appeared to be an acceptable therapeutic option for some patients with peritoneal metastasis. The National Comprehensive Cancer Network (NCCN) guidelines for colon cancer recently added the following footnote regarding the therapeutic strategy for peritoneal metastases: "If R0 resection can be achieved, surgical resection of isolated peritoneal disease may be considered at experienced centers." This study investigated the efficacy of R0 resection of peritoneal metastasis from colorectal cancer without cytoreductive surgery or hyperthermic intraperitoneal chemotherapy (HIPEC).BACKGROUNDThe National Comprehensive Cancer Network (NCCN) guidelines for colon cancer recently added the following footnote regarding the therapeutic strategy for peritoneal metastases: "If R0 resection can be achieved, surgical resection of isolated peritoneal disease may be considered at experienced centers." This study investigated the efficacy of R0 resection of peritoneal metastasis from colorectal cancer without cytoreductive surgery or hyperthermic intraperitoneal chemotherapy (HIPEC).This retrospective cohort study was conducted at a single-institution tertiary care cancer center. Among 496 consecutive M1c colorectal cancer patients, R0 resection was achieved for 94 patients (19%). The subjects were 78 consecutive patients with colorectal cancer and simultaneous peritoneal metastasis but no other distant metastases who underwent R0 resection at the National Cancer Center Hospital from 1971 to 2016 (16% of all M1c patients). Overall survival (OS) was investigated, and clinicopathologic variables were analyzed for prognostic significance.METHODSThis retrospective cohort study was conducted at a single-institution tertiary care cancer center. Among 496 consecutive M1c colorectal cancer patients, R0 resection was achieved for 94 patients (19%). The subjects were 78 consecutive patients with colorectal cancer and simultaneous peritoneal metastasis but no other distant metastases who underwent R0 resection at the National Cancer Center Hospital from 1971 to 2016 (16% of all M1c patients). Overall survival (OS) was investigated, and clinicopathologic variables were analyzed for prognostic significance.No perioperative mortality was noted. The 3-year OS rate was 45%, and the 5-year OS rate was 28.7%. The median survival time was 33.4 months. Notably, 17 patients survived for more than 5 years, and 9 of these patients did not receive any chemotherapy. Multivariate analysis showed cancer location in the colon and harvesting of 12 or more lymph nodes to be independent factors associated with a better prognosis.RESULTSNo perioperative mortality was noted. The 3-year OS rate was 45%, and the 5-year OS rate was 28.7%. The median survival time was 33.4 months. Notably, 17 patients survived for more than 5 years, and 9 of these patients did not receive any chemotherapy. Multivariate analysis showed cancer location in the colon and harvesting of 12 or more lymph nodes to be independent factors associated with a better prognosis.From the perspective of long-term outcomes and no perioperative mortality, R0 resection of peritoneal metastasis from colorectal cancer, without complete peritonectomy or HIPEC, appeared to be an acceptable therapeutic option for some patients with peritoneal metastasis.CONCLUSIONSFrom the perspective of long-term outcomes and no perioperative mortality, R0 resection of peritoneal metastasis from colorectal cancer, without complete peritonectomy or HIPEC, appeared to be an acceptable therapeutic option for some patients with peritoneal metastasis. The National Comprehensive Cancer Network (NCCN) guidelines for colon cancer recently added the following footnote regarding the therapeutic strategy for peritoneal metastases: "If R0 resection can be achieved, surgical resection of isolated peritoneal disease may be considered at experienced centers." This study investigated the efficacy of R0 resection of peritoneal metastasis from colorectal cancer without cytoreductive surgery or hyperthermic intraperitoneal chemotherapy (HIPEC). This retrospective cohort study was conducted at a single-institution tertiary care cancer center. Among 496 consecutive M1c colorectal cancer patients, R0 resection was achieved for 94 patients (19%). The subjects were 78 consecutive patients with colorectal cancer and simultaneous peritoneal metastasis but no other distant metastases who underwent R0 resection at the National Cancer Center Hospital from 1971 to 2016 (16% of all M1c patients). Overall survival (OS) was investigated, and clinicopathologic variables were analyzed for prognostic significance. No perioperative mortality was noted. The 3-year OS rate was 45%, and the 5-year OS rate was 28.7%. The median survival time was 33.4 months. Notably, 17 patients survived for more than 5 years, and 9 of these patients did not receive any chemotherapy. Multivariate analysis showed cancer location in the colon and harvesting of 12 or more lymph nodes to be independent factors associated with a better prognosis. From the perspective of long-term outcomes and no perioperative mortality, R0 resection of peritoneal metastasis from colorectal cancer, without complete peritonectomy or HIPEC, appeared to be an acceptable therapeutic option for some patients with peritoneal metastasis.
Author	Tsukamoto, Shunsuke Ochiai, Hiroki Kanemitsu, Yukihide Shida, Dai
Author_xml	– sequence: 1 givenname: Dai surname: Shida fullname: Shida, Dai email: dshida@ncc.go.jp organization: Colorectal Surgery Division, National Cancer Center Hospital – sequence: 2 givenname: Shunsuke surname: Tsukamoto fullname: Tsukamoto, Shunsuke organization: Colorectal Surgery Division, National Cancer Center Hospital – sequence: 3 givenname: Hiroki surname: Ochiai fullname: Ochiai, Hiroki organization: Colorectal Surgery Division, National Cancer Center Hospital – sequence: 4 givenname: Yukihide surname: Kanemitsu fullname: Kanemitsu, Yukihide organization: Colorectal Surgery Division, National Cancer Center Hospital
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/29063295$$D View this record in MEDLINE/PubMed
BookMark	eNp9Uctq3TAUFCWhefUDuiladuNUsiT7ehlM0wRuSMmDLIUsH-c62JIryQX_Uz-yx9y0hS4CAunozIyOZk7IgfMOCPnI2TnPpfoSOZNCZoyXWcGFyMp35JgrvJHFhh_gmRWbrMoLdUROYnxhCBRMvSdHecUKkVfqmPzaevecPUAY6e2crB8h0osuQaB3jN5BBJt676jv6P3i7C545-dIv0PoE85iBnoDyURcfaRd8COt_eADsrBVG2dR6KlPOz8nWi8JO-2Mij-B3s_hGcJCfaBXywQh7XCG3tJrl4KZ_unXOxj92jTTckYOOzNE-PC6n5LHy68P9VW2vf12XV9sMyuVTJnMFfDCgGDMQCs6s2mwgNZalXNVNEKqVmxUWbSGdQ0zpc0blldS8k4UbafEKfm8152C_zFDTHrso4VhMA7w-5pXSrFSSLlCP71C52aEVk-hH01Y9B-HEcD3ABt8jAG6vxDO9Jqi3qeoMRy9pqhL5JT_cWyfzBoEetMPbzLzPTPiKw4N1i9-Dg7NeoP0G42GtTI
CitedBy_id	crossref_primary_10_1007_s11605_018_4044_y crossref_primary_10_1245_s10434_018_6890_y crossref_primary_10_1245_s10434_018_6436_3 crossref_primary_10_1002_cam4_3972 crossref_primary_10_1007_s12328_024_01931_0 crossref_primary_10_1093_jjco_hyy198 crossref_primary_10_1186_s12885_018_4241_9 crossref_primary_10_1016_j_ejso_2025_109703 crossref_primary_10_1016_j_suronc_2019_10_018 crossref_primary_10_3390_cancers13122964 crossref_primary_10_1245_s10434_019_07209_x crossref_primary_10_1038_s41598_018_37169_3 crossref_primary_10_1007_s00384_019_03408_w crossref_primary_10_1007_s11605_021_05122_x crossref_primary_10_1109_TRPMS_2019_2902015 crossref_primary_10_1097_JS9_0000000000000809 crossref_primary_10_1109_TRPMS_2020_3029982 crossref_primary_10_1245_s10434_020_08208_z crossref_primary_10_1007_s00595_020_02180_7 crossref_primary_10_1016_j_ejso_2019_07_019 crossref_primary_10_1186_s12957_020_1784_4 crossref_primary_10_1016_j_soi_2025_100136 crossref_primary_10_1186_s12957_019_1646_0 crossref_primary_10_1245_s10434_020_08242_x crossref_primary_10_1186_s12885_019_5956_y crossref_primary_10_1245_s10434_018_6782_1 crossref_primary_10_1002_cam4_2598 crossref_primary_10_1007_s00423_024_03374_0 crossref_primary_10_1007_s11548_022_02698_w crossref_primary_10_1016_j_surg_2018_07_027 crossref_primary_10_1245_s10434_023_14191_y crossref_primary_10_1007_s00384_023_04434_5 crossref_primary_10_1007_s00104_019_0982_5 crossref_primary_10_1186_s12957_022_02693_0 crossref_primary_10_3390_cancers12010122 crossref_primary_10_1007_s10147_019_01485_z crossref_primary_10_1016_j_ejso_2021_02_015 crossref_primary_10_1245_s10434_023_14264_y crossref_primary_10_1007_s10147_019_01562_3 crossref_primary_10_1097_DCR_0000000000002059
Cites_doi	10.1016/S1470-2045(12)70210-3 10.1245/s10434-016-5698-x 10.1097/SLA.0b013e3181d9765d 10.1007/s00535-013-0820-3 10.1016/S1470-2045(16)30500-9 10.1007/s10147-015-0815-6 10.1007/s00595-013-0735-x 10.1002/bjs.7032 10.1007/s10147-012-0505-6 10.1093/jjco/hyu114 10.1200/JCO.2009.23.9285 10.1159/000449348 10.1007/s00535-015-1122-8 10.1159/000442027 10.6004/jnccn.2017.0036 10.1007/s10147-017-1101-6
ContentType	Journal Article
Copyright	Society of Surgical Oncology 2017
Copyright_xml	– notice: Society of Surgical Oncology 2017
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1245/s10434-017-6133-7
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1534-4681
EndPage	178
ExternalDocumentID	29063295 10_1245_s10434_017_6133_7
Genre	Journal Article
GroupedDBID	--- -53 -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 199 1N0 1SB 203 23M 28- 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2WC 2~H 30V 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5VS 67Z 6J9 6NX 78A 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABOCM ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACAOD ACBXY ACDTI ACGFO ACGFS ACHSB ACHVE ACHXU ACIHN ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACREN ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEAQA AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFJLC AFKRA AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGVAE AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BAWUL BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI C1A CAG CCPQU COF CS3 CSCUP DDRTE DIK DL5 DNIVK DPUIP E3Z EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GX1 GXS H13 HEOXT HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IH2 IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH L7B LAS LLZTM M1P M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD OWW P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 WOQ YFH YLTOR Z45 Z7U Z7X Z82 Z83 Z87 Z8O Z8V Z91 ZMTXR ZOVNA AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFFHD AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7X8 PUEGO
ID	FETCH-LOGICAL-c454t-425e16ae300aed3fa8bae3edcc52156b345d38576da0fb0a7c2b029441f36df53
IEDL.DBID	RSV
ISICitedReferencesCount	53
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000418583300028&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1068-9265 1534-4681
IngestDate	Thu Oct 02 04:13:36 EDT 2025 Wed Feb 19 02:35:12 EST 2025 Tue Nov 18 21:44:35 EST 2025 Sat Nov 29 03:27:53 EST 2025 Fri Feb 21 02:44:58 EST 2025
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	NCCN guidelines Peritoneal metastasis R0 resection Colorectal cancer
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c454t-425e16ae300aed3fa8bae3edcc52156b345d38576da0fb0a7c2b029441f36df53
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
PMID	29063295
PQID	1955073445
PQPubID	23479
PageCount	6
ParticipantIDs	proquest_miscellaneous_1955073445 pubmed_primary_29063295 crossref_primary_10_1245_s10434_017_6133_7 crossref_citationtrail_10_1245_s10434_017_6133_7 springer_journals_10_1245_s10434_017_6133_7
PublicationCentury	2000
PublicationDate	2018-01-01
PublicationDateYYYYMMDD	2018-01-01
PublicationDate_xml	– month: 01 year: 2018 text: 2018-01-01 day: 01
PublicationDecade	2010
PublicationPlace	Cham
PublicationPlace_xml	– name: Cham – name: United States
PublicationTitle	Annals of surgical oncology
PublicationTitleAbbrev	Ann Surg Oncol
PublicationTitleAlternate	Ann Surg Oncol
PublicationYear	2018
Publisher	Springer International Publishing
Publisher_xml	– name: Springer International Publishing
References	CR3 CR6 Ozawa, Kotake, Kobayashi, Kobayashi, Sugihara (CR16) 2014; 44 Elias, Gilly, Boutitie (CR8) 2010; 28 Noura, Ohue, Ito (CR13) 2016; 33 Ihemelandu, Sugarbaker (CR9) 2017; 244 Jones, Kokudo, Folprecht (CR12) 2016; 6 Kobayashi, Kotake, Sugihara (CR7) 2014; 44 Morris, Forman, Thomas (CR11) 2010; 97 Kobayashi, Kotake, Funahashi (CR17) 2014; 49 Watanabe, Muro, Ajioka (CR1) 2017 Kobayashi, Kotake, Sugihara (CR14) 2014; 19 Sugarbaker, Ryan (CR4) 2012; 13 Elias, Glehen, Pocard (CR10) 2010; 251 Franko, Shi, Meyers (CR2) 2016; 17 Furuhata, Okita, Nishidate (CR18) 2015; 20 Sato, Maeda, Kotake, Sugihara, Takahashi (CR15) 2016; 51 Benson, Venook, Cederquist (CR5) 2017; 15 H Sato (6133_CR15) 2016; 51 H Kobayashi (6133_CR17) 2014; 49 J Franko (6133_CR2) 2016; 17 H Kobayashi (6133_CR7) 2014; 44 T Watanabe (6133_CR1) 2017 S Noura (6133_CR13) 2016; 33 RP Jones (6133_CR12) 2016; 6 EJ Morris (6133_CR11) 2010; 97 C Ihemelandu (6133_CR9) 2017; 244 6133_CR6 6133_CR3 T Furuhata (6133_CR18) 2015; 20 H Kobayashi (6133_CR14) 2014; 19 PH Sugarbaker (6133_CR4) 2012; 13 D Elias (6133_CR8) 2010; 28 D Elias (6133_CR10) 2010; 251 H Ozawa (6133_CR16) 2014; 44 AB Benson III (6133_CR5) 2017; 15 30251024 - Ann Surg Oncol. 2018 Dec;25(Suppl 3):832-833
References_xml	– volume: 13 start-page: e362 year: 2012 end-page: e369 ident: CR4 article-title: Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach? publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(12)70210-3 – volume: 244 start-page: 898 year: 2017 end-page: 905 ident: CR9 article-title: Management for peritoneal metastasis of colonic origin: role of cytoreductive surgery and perioperative intraperitoneal chemotherapy: a single institution’s experience during two decades publication-title: Ann Surg Oncol. doi: 10.1245/s10434-016-5698-x – volume: 251 start-page: 896 year: 2010 end-page: 901 ident: CR10 article-title: A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix publication-title: Ann Surg. doi: 10.1097/SLA.0b013e3181d9765d – ident: CR3 – volume: 49 start-page: 646 year: 2014 end-page: 654 ident: CR17 article-title: Clinical benefit of surgery for stage IV colorectal cancer with synchronous peritoneal metastasis publication-title: J Gastroenterol. doi: 10.1007/s00535-013-0820-3 – volume: 17 start-page: 1709 year: 2016 end-page: 1719 ident: CR2 article-title: Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(16)30500-9 – volume: 20 start-page: 922 year: 2015 end-page: 927 ident: CR18 article-title: Oncological benefit of primary tumor resection with high tie lymph node dissection in unresectable colorectal cancer with synchronous peritoneal metastasis: a propensity score analysis of data from a multi-institute database publication-title: Int J Clin Oncol. doi: 10.1007/s10147-015-0815-6 – volume: 44 start-page: 1643 year: 2014 end-page: 1650 ident: CR16 article-title: Prognostic factors for peritoneal carcinomatosis originating from colorectal cancer: an analysis of 921 patients from a multi-institutional database publication-title: Surg Today. doi: 10.1007/s00595-013-0735-x – ident: CR6 – year: 2017 ident: CR1 article-title: Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer publication-title: Int J Clin Oncol. – volume: 97 start-page: 1110 year: 2010 end-page: 1118 ident: CR11 article-title: Surgical management and outcomes of colorectal cancer liver metastases publication-title: Br J Surg. doi: 10.1002/bjs.7032 – volume: 19 start-page: 98 year: 2014 end-page: 105 ident: CR14 article-title: Outcomes of surgery without HIPEC for synchronous peritoneal metastasis from colorectal cancer: data from a multi-center registry publication-title: Int J Clin Oncol. doi: 10.1007/s10147-012-0505-6 – volume: 44 start-page: 898 year: 2014 end-page: 902 ident: CR7 article-title: Study Group for Peritoneal Metastasis from Colorectal Cancer by the Japanese Society for Cancer of the C, Rectum. Enhancing the objectivity of the Japanese classification of peritoneal metastases from colorectal cancer publication-title: Jpn J Clin Oncol. doi: 10.1093/jjco/hyu114 – volume: 28 start-page: 63 year: 2010 end-page: 68 ident: CR8 article-title: Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study publication-title: J Clin Oncol. doi: 10.1200/JCO.2009.23.9285 – volume: 6 start-page: 66 year: 2016 end-page: 71 ident: CR12 article-title: Colorectal liver metastases: a critical review of state of the art publication-title: Liver Cancer. doi: 10.1159/000449348 – volume: 51 start-page: 465 year: 2016 end-page: 472 ident: CR15 article-title: Factors affecting recurrence and prognosis after R0 resection for colorectal cancer with peritoneal metastasis publication-title: J Gastroenterol. doi: 10.1007/s00535-015-1122-8 – volume: 33 start-page: 66 year: 2016 end-page: 73 ident: CR13 article-title: New staging system for colorectal cancer patients with synchronous peritoneal metastasis in accordance with the Japanese classification of colorectal carcinoma: a multi-institutional study publication-title: Dig Surg. doi: 10.1159/000442027 – volume: 15 start-page: 370 year: 2017 end-page: 398 ident: CR5 article-title: Colon Cancer, version 1.2017, NCCN Clinical Practice Guidelines in Oncology publication-title: J Natl Compr Canc Netw. doi: 10.6004/jnccn.2017.0036 – volume: 97 start-page: 1110 year: 2010 ident: 6133_CR11 publication-title: Br J Surg. doi: 10.1002/bjs.7032 – volume: 44 start-page: 898 year: 2014 ident: 6133_CR7 publication-title: Jpn J Clin Oncol. doi: 10.1093/jjco/hyu114 – volume: 244 start-page: 898 year: 2017 ident: 6133_CR9 publication-title: Ann Surg Oncol. doi: 10.1245/s10434-016-5698-x – volume: 251 start-page: 896 year: 2010 ident: 6133_CR10 publication-title: Ann Surg. doi: 10.1097/SLA.0b013e3181d9765d – volume: 51 start-page: 465 year: 2016 ident: 6133_CR15 publication-title: J Gastroenterol. doi: 10.1007/s00535-015-1122-8 – volume: 44 start-page: 1643 year: 2014 ident: 6133_CR16 publication-title: Surg Today. doi: 10.1007/s00595-013-0735-x – volume: 13 start-page: e362 year: 2012 ident: 6133_CR4 publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(12)70210-3 – volume: 17 start-page: 1709 year: 2016 ident: 6133_CR2 publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(16)30500-9 – volume: 33 start-page: 66 year: 2016 ident: 6133_CR13 publication-title: Dig Surg. doi: 10.1159/000442027 – volume: 6 start-page: 66 year: 2016 ident: 6133_CR12 publication-title: Liver Cancer. doi: 10.1159/000449348 – year: 2017 ident: 6133_CR1 publication-title: Int J Clin Oncol. doi: 10.1007/s10147-017-1101-6 – volume: 20 start-page: 922 year: 2015 ident: 6133_CR18 publication-title: Int J Clin Oncol. doi: 10.1007/s10147-015-0815-6 – volume: 19 start-page: 98 year: 2014 ident: 6133_CR14 publication-title: Int J Clin Oncol. doi: 10.1007/s10147-012-0505-6 – ident: 6133_CR3 – volume: 15 start-page: 370 year: 2017 ident: 6133_CR5 publication-title: J Natl Compr Canc Netw. doi: 10.6004/jnccn.2017.0036 – volume: 49 start-page: 646 year: 2014 ident: 6133_CR17 publication-title: J Gastroenterol. doi: 10.1007/s00535-013-0820-3 – ident: 6133_CR6 – volume: 28 start-page: 63 year: 2010 ident: 6133_CR8 publication-title: J Clin Oncol. doi: 10.1200/JCO.2009.23.9285 – reference: 30251024 - Ann Surg Oncol. 2018 Dec;25(Suppl 3):832-833
SSID	ssj0017305
Score	2.4543445
Snippet	Background The National Comprehensive Cancer Network (NCCN) guidelines for colon cancer recently added the following footnote regarding the therapeutic... The National Comprehensive Cancer Network (NCCN) guidelines for colon cancer recently added the following footnote regarding the therapeutic strategy for...
SourceID	proquest pubmed crossref springer
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	173
SubjectTerms	Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Chemotherapy, Adjuvant Colorectal Cancer Colorectal Neoplasms - drug therapy Colorectal Neoplasms - pathology Colorectal Neoplasms - surgery Cytoreduction Surgical Procedures Female Fluorouracil - administration & dosage Humans Hyperthermia, Induced Lymph Node Excision Male Medicine Medicine & Public Health Metastasectomy Middle Aged Neoplasm, Residual Oncology Oxaliplatin - administration & dosage Peritoneal Neoplasms - drug therapy Peritoneal Neoplasms - pathology Peritoneal Neoplasms - secondary Peritoneal Neoplasms - surgery Prognosis Retrospective Studies Surgery Surgical Oncology Survival Rate Time Factors Tumor Burden
Title	Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy
URI	https://link.springer.com/article/10.1245/s10434-017-6133-7 https://www.ncbi.nlm.nih.gov/pubmed/29063295 https://www.proquest.com/docview/1955073445
Volume	25
WOSCitedRecordID	wos000418583300028&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1534-4681 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017305 issn: 1068-9265 databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9wwEBZNWkpfeh_bI6jQpxaDV5elx7A0pJCkIZum-yZkWWoXWjvY3sL-p_zIzPjYENIW2kcja2Q8h2Y0M58IeTeNLqhCGNA0pxMhMpYY431iomE-Ssl8V_J_dpAdHenFwhwPfdzNWO0-piQ7S90hIAiJzW6CY8UEtrVxnmRb5Dbsdhq18WR-tkkdgMjKLsWpQJOZkkMq87ckrm9GNzzMG9nRbtPZe_Bfn_uQ3B98TLrbC8UjciuUj8ndwyGL_oRcHFTlt-QUbDL9vGqBXGjoLt4VTk9SiqV4Xa8DrSKdr0uP6LnVqqHHIKuI3A2UD0PrwKtslg3F9hQ6AwuKlhOGZihFNf26bL9Xq5bO1hDTIzosWlU673uwaVXTfYh_a3Q-fy49_YQnzOdX9BHFYOgMWz8lX_Y-ns72k-HWhsQLKdoEjECYKhd4mrpQ8Oh0Dg-h8B48BalyLmTBNYQ5hUtjnrrMszxlBtyyyFURJX9GtktY7QWhSmkVGUY8Phch4O0NKvLC6MhgklATko7ss36ANMebNX5YDG2AC7bnggUuWOSCzSbk_WbKeY_n8beX344yYUHrMJXiygC_3E4N4sBxIeSEPO-FZUMOAfQ5MzDyYZQMOxiG5s9rvfynt1-Re-C56f4s6DXZbutVeEPu-F_tsql3yFa20DudWlwC9hIJBg
linkProvider	Springer Nature
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zj9MwELZgQSwv3Ec5jcQTKFLqK_HjqmLVFW1Zbcuyb5bj2FBpSVZJitT_xI9kJkcRWkCCx8jxOMqMxzOemW8IeT0O1qtcaNhpNo2ESFiktXORDpq5ICVzbcr_6SxZLNKzM33c13HXQ7b7EJJsNXWLgCAkFrsJjhkTWNbGeZRcJdcEHFiYx3eyPN2FDkBkZRviVLCTmZJ9KPO3JH49jC5ZmJeio-2hc3j7vz73DrnV25j0oBOKu-SKL-6RG_M-in6ffJ-VxedoBTqZftg0QM7X9AB7hdOTmGIqXlvrQMtAl9vCIXpuuanpMcgqIncD5blvLFiV9bqmWJ5CJ6BBUXPC0ASlqKKf1s2XctPQyRZ8ekSHRa1Kl10NNi0rOgX_t0Lj8-va0SO8Yb74SR9RDPrKsO0D8vHw3WoyjfquDZETUjQRKAE_VtbzOLY-58GmGTz43DmwFKTKuJA5T8HNyW0cstgmjmUx02CWBa7yIPlDslfAao8JVSpVgaHH4zLhPXZvUIHnOg0MJgk1IvHAPuN6SHPsrHFu0LUBLpiOCwa4YJALJhmRN7spFx2ex99efjXIhIFdh6EUW3j45WasEQeOCyFH5FEnLDtyCKDPmYaRt4NkmF4x1H9e68k_vf2S7E9X85mZHS3ePyU3wYpLu3uhZ2SvqTb-ObnuvjXrunrRbo4fKzMLAg
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zj9MwELZgQSteuI9yGoknULSpr8SPq0K1K7qlosuyb5bj2FAJkipJkfqf-JHM5ChCC0iIx8jxOMqMxzOemW8IeTEO1qtcaNhpNo2ESFiktXORDpq5ICVzbcr_2SyZz9Pzc73o-5zWQ7b7EJLsahoQpaloDtZ56NAQhMTCN8ExewJL3DiPksvkisCeQeiuL892YQQQX9mGOxXsaqZkH9b8LYlfD6YL1uaFSGl7AE1v_Pen3yTXe9uTHnbCcotc8sVtsn_SR9fvkO-zsvgUnYKupu82DZD2NT3EHuL0fUwxRa-tgaBloMtt4RBVt9zUdAEyjIjeQPnENxaszXpVUyxboRPQrKhRYWiC0lXRj6vmc7lp6GQLvj6ixqK2pcuuNpuWFT0Cv7hCo_TrytFjvHle_6SP6AZ9xdj2LvkwfXM6OYr6bg6RE1I0ESgHP1bW8zi2PufBphk8-Nw5sCCkyriQOU_B_cltHLLYJo5lMdNgrgWu8iD5PbJXwGoPCFUqVYGhJ-Qy4T12dVCB5zoNDCYJNSLxwErjeqhz7LjxxaDLA1wwHRcMcMEgF0wyIi93U9YdzsffXn4-yIeB3YghFlt4-OVmrBEfjgshR-R-Jzg7cgisz5mGkVeDlJheYdR_XuvhP739jOwvXk_N7Hj-9hG5BsZd2l0XPSZ7TbXxT8hV961Z1dXTdp_8AJ2NE-Y
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-Term+Outcomes+After+R0+Resection+of+Synchronous+Peritoneal+Metastasis+from+Colorectal+Cancer+Without+Cytoreductive+Surgery+or+Hyperthermic+Intraperitoneal+Chemotherapy&rft.jtitle=Annals+of+surgical+oncology&rft.au=Shida%2C+Dai&rft.au=Tsukamoto%2C+Shunsuke&rft.au=Ochiai%2C+Hiroki&rft.au=Kanemitsu%2C+Yukihide&rft.date=2018-01-01&rft.pub=Springer+International+Publishing&rft.issn=1068-9265&rft.eissn=1534-4681&rft.volume=25&rft.issue=1&rft.spage=173&rft.epage=178&rft_id=info:doi/10.1245%2Fs10434-017-6133-7&rft.externalDocID=10_1245_s10434_017_6133_7
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1068-9265&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1068-9265&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1068-9265&client=summon